BioSpace News Archive

Deals

Delcath Systems Closes $7 Million Private Placement

Delcath Systems, Inc. confirmed the closing of the previously announced private placement with certain accredited investors comprised of existing investors.

March 20, 2024
·
5 min read
Drug Development

Inhalon Biopharma Announces Positive Results from Study Demonstrating Superior Safety and Efficacy of its Inhaled Antibody Platform Over Systemic Dosing

Inhalon Biopharma today announced initial results from a landmark Phase 1b study that directly compares the distribution and retention of antibodies throughout the human respiratory tract following both inhaled and intravenous (IV) delivery.

March 20, 2024
·
3 min read
Genetown

Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session

Alnylam Pharmaceuticals, Inc. announced today that it will host a webcast event to discuss results from the KARDIA-2 Phase 2 study of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) in development for the treatment of hypertension, at the American College of Cardiology (ACC) Scientific Session on Sunday, April 7, 2024 at 7:00 pm ET.

March 20, 2024
·
2 min read
healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program

HUNTSVILLE, Ala., March 20, 2024 – healthŌme®, Inc., a leading genomics-based, precision health management company serving the life and critical illness industries, and GalenusRx, Inc.,

March 20, 2024
·
5 min read
Pharm Country

RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury

RespireRx Pharmaceuticals Inc. is pleased to announce that, as part of an ongoing collaboration, a scientist team led by Dr. David Fuller of the University of Florida has published a peer-reviewed research article describing the ability of CX1739.

March 20, 2024
·
14 min read
Business

Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health

Kane Biotech Inc. announces today that it has extended the exclusivity period on the offer for its interest in STEM Animal Health that it announced on December 20, 2023, from March 19, 2024 until March 31, 2024.

March 20, 2024
·
2 min read
Drug Development

Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia

Antengene Corporation Limited today announced that it has initiated the dose expansion portion of the Phase II CLINCH study of ATG-022 (Claudin 18.2 antibody-drug conjugate[ADC]) in China and Australia.

March 20, 2024
·
4 min read
Drug Development

Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

Antennova, a clinical-stage biotech company focused on oncology today announced completion of the first dosing cohort in the Phase I study for the anti-CD24 antibody, ATN-031 (also known as ATG-031).

March 20, 2024
·
5 min read
BioMidwest

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

VolitionRx Limited has agreed a supply agreement with Fujifilm Vet Systems Co. Ltd, a leading veterinary diagnostic laboratory service, to launch the Nu.Q® Vet Cancer Test to veterinarians in Japan.

March 20, 2024
·
6 min read
Pharm Country

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Lucid Diagnostics Inc. today announced that four abstracts related to its groundbreaking technologies, including its EsoGuard® Esophageal DNA Test.

March 20, 2024
·
4 min read